Chimeric Therapeutics Raises $2.7m in shortfall placement
Chimeric Therapeutics (CHM) announces details of its retail entitlement offer shortfall placement after failing to raise its...
Chimeric Therapeutics Raises $7.37m for licence agreements
Chimeric Therapeutics (CHM) successfully completes its institutional entitlement offer and raises $7.37 million
This institutional entitlement offer...
